SCHEMBL800951

SCHEMBL800951

CCNCC(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2016633 0.97
Acetic Acid SCHEMBL28343365 0.93 GAA (0.44)
SCHEMBL73416 0.85 TSHR (0.56)
SCHEMBL23388751 0.84 RECQL (0.57)
SCHEMBL31092896 0.83 ALDH1A1 (0.43)
Hydrochloric Acid SCHEMBL112927 0.82 TSHR (0.53)
SCHEMBL17493688 0.81
SCHEMBL2361759 0.80 TSHR (0.50)
SCHEMBL1396293 0.80
SCHEMBL10368064 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12629341-B2 Functional derivatives of maleimide copolymers for nanodisc production THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2026-05-19 US claimed
US-20220347114-A1 FUNCTIONAL DERIVATIVES OF MALEIMIDE COPOLYMERS FOR NANODISC PRODUCTION THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2022-11-03 US claimed
EP-4049035-A1 FUNCTIONAL DERIVATIVES OF MALEIMIDE COPOLYMERS FOR NANODISC PRODUCTION The Governors Of The University Of Alberta (CA) 2022-08-31 EP claimed
US-11802107-B2 Compounds and methods of use SIGNUM BIOSCIENCES, INC. (US) 2023-10-31 US disclosed
US-20230174467-A1 COMPOUNDS AND METHODS OF USE SIGNUM BIOSCIENCES, INC. (US) 2023-06-08 US disclosed
CN-110475474-B Compounds and methods of use 西格纳姆生物科学公司 2022-11-04 CN disclosed
US-11274092-B2 Potassium channel inhibitors ACESION PHARMA APS (DK) 2022-03-15 US disclosed
EP-3946635-A2 LOCALLY ACTING TOLL-LIKE RECEPTOR 7 (TLR7) AND/OR TLR8 AGONIST IMMUNOTHERAPY COMPOUNDS AND THEIR USES ALTIMMUNE UK LIMITED (GB) 2022-02-09 EP disclosed
WO-2021121282-A1 PREPARATION AND APPLICATION OF CLASS OF N-CONTAINING HETEROCYCLIC COMPOUNDS WITH IMMUNOMODULATORY FUNCTION 上海轶诺药业有限公司 2021-06-24 WO disclosed
US-20210188804-A1 NOVEL POTASSIUM CHANNEL INHIBITORS ACESION PHARMA APS (DK) 2021-06-24 US disclosed
CN-109153667-B Novel potassium channel inhibitors 阿塞西翁制药公司 2021-04-02 CN disclosed
US-4946987-A Treatment for complications of diabetes AYERST, MCKENNA & HARRISON, INC. (CA) 1990-08-07 US disclosed
EP-0148883-B1 ALLOPURINOL PRODRUGS A/S GEA Farmaceutisk Fabrik (DK) 1990-02-14 EP disclosed
US-4705882-A ALDOSE REDUCTASE INHIBITORS, ANTIDIABETIC AGENTS AYERST, MCKENNA & HARRISON, INC. (CA) 1987-11-10 US disclosed
US-4694006-A Acyl- or acyloxymethyl-allopurinol prodrugs A/S GEA (DK) 1987-09-15 US disclosed
US-4600724-A ALDOSE REDUCTASE INHIBITOR, DIABETES AYERST, MCKENNA & HARRISON, INC. (CA) 1986-07-15 US disclosed
US-4568693-A ANTIDIATBETIC AGENTS AYERST, MCKENNA & HARRISON, INC. (CA) 1986-02-04 US disclosed
EP-0148883-A1 ALLOPURINOL PRODRUGS. GEA AS (DK) 1985-07-24 EP disclosed
WO-1985000368-A1 ALLOPURINOL PRODRUGS A/S GEA (DK) 1985-01-31 WO disclosed
US-4439617-A TREATING DIABETES, ENZYME INHIBITOR AYERST, MCKENNA & HARRISON INC. (CA) 1984-03-27 US disclosed